NKMax Co Ltd banner
N

NKMax Co Ltd
KOSDAQ:182400

Watchlist Manager
NKMax Co Ltd
KOSDAQ:182400
Watchlist
Price: 2 020 KRW 9.54%
Market Cap: ₩172.7B

NKMax Co Ltd
Short-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

NKMax Co Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
N
NKMax Co Ltd
KOSDAQ:182400
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Short-Term Debt
₩3.2T
CAGR 3-Years
80%
CAGR 5-Years
49%
CAGR 10-Years
26%
SK Bioscience Co Ltd
KRX:302440
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

NKMax Co Ltd
Glance View

Market Cap
172.7B KRW
Industry
Biotechnology

NKMAX Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-10-23. The firm is involved in the production and sale of recombinant proteins, monoclonal antibodies, NK cell activity test kits, cell therapy products, and in the provision of other related services. The NK cell activity test kits are provided under the name of NK Vue. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
1 858.67 KRW
Overvaluation 8%
Intrinsic Value
Price ₩2 020
N

See Also

What is NKMax Co Ltd's Short-Term Debt?
Short-Term Debt
0 KRW

Based on the financial report for Dec 31, 2025, NKMax Co Ltd's Short-Term Debt amounts to 0 KRW.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett